Emtricitabine/Tenofovir disoproxil Krka

emtricitabine; tenofovir disoproxil succinate · KRKA, d.d., Novo mesto

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Emtricitabine/Tenofovir disoproxil Krka, covering 2025-01-31 to 2025-01-31. Get the full timeline:

Most recent: EMA Authorised: Emtricitabine/Tenofovir disoproxil Krka (emtricitabine;tenofovir disoproxil succinate) — KRKA, d.d., Novo mesto